M. Tatar Et Al. , "COST-EFFECTIVENESS OF OMALIZUMAB IN CHRONIC IDIOPATHIC URTICARIA REFRACTORY TO H1-ANTIHISTAMINES IN TURKEY," VALUE IN HEALTH , vol.17, no.7, 2014
Tatar, M. Et Al. 2014. COST-EFFECTIVENESS OF OMALIZUMAB IN CHRONIC IDIOPATHIC URTICARIA REFRACTORY TO H1-ANTIHISTAMINES IN TURKEY. VALUE IN HEALTH , vol.17, no.7 .
Tatar, M., Sezen, S., Senturk, A., Balp, M. M., Saylan, M., & Keskinaslan, A., (2014). COST-EFFECTIVENESS OF OMALIZUMAB IN CHRONIC IDIOPATHIC URTICARIA REFRACTORY TO H1-ANTIHISTAMINES IN TURKEY. VALUE IN HEALTH , vol.17, no.7.
Tatar, MEHTAP Et Al. "COST-EFFECTIVENESS OF OMALIZUMAB IN CHRONIC IDIOPATHIC URTICARIA REFRACTORY TO H1-ANTIHISTAMINES IN TURKEY," VALUE IN HEALTH , vol.17, no.7, 2014
Tatar, MEHTAP Et Al. "COST-EFFECTIVENESS OF OMALIZUMAB IN CHRONIC IDIOPATHIC URTICARIA REFRACTORY TO H1-ANTIHISTAMINES IN TURKEY." VALUE IN HEALTH , vol.17, no.7, 2014
Tatar, M. Et Al. (2014) . "COST-EFFECTIVENESS OF OMALIZUMAB IN CHRONIC IDIOPATHIC URTICARIA REFRACTORY TO H1-ANTIHISTAMINES IN TURKEY." VALUE IN HEALTH , vol.17, no.7.
@article{article, author={MEHTAP TATAR Et Al. }, title={COST-EFFECTIVENESS OF OMALIZUMAB IN CHRONIC IDIOPATHIC URTICARIA REFRACTORY TO H1-ANTIHISTAMINES IN TURKEY}, journal={VALUE IN HEALTH}, year=2014}